Skip to main content
. Author manuscript; available in PMC: 2012 Dec 10.
Published in final edited form as: Crit Care Clin. 2009 Apr;25(2):373–Contents. doi: 10.1016/j.ccc.2008.12.006

Fig. 4.

Fig. 4

Exchange transfusion using polyHb-Fg did not change the clotting time. However, exchange transfusion of polyHb of more than 80% resulted in clotting problems because there were insufficient platelets or clotting factors. (From Wong N, Chang TMS. Polyhemoglobin-fibrinogen a novel blood substitute with platelet-like activity for extreme hemodilution. Artif Cells Blood Substit Biotechnol, 2007; with permission.)